PCR83 Defining the Smallest Worthwhile Effect of Treatment for Progressive Nervous System Tumors in People with NF2-Related Schwannomatosis: Qualitative Patient Interview Results from a Multicenter Clinical Trial
Jun 1, 2023, 00:00
10.1016/j.jval.2023.03.1861
https://www.valueinhealthjournal.com/article/S1098-3015(23)01961-7/fulltext
Title :
PCR83 Defining the Smallest Worthwhile Effect of Treatment for Progressive Nervous System Tumors in People with NF2-Related Schwannomatosis: Qualitative Patient Interview Results from a Multicenter Clinical Trial
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(23)01961-7&doi=10.1016/j.jval.2023.03.1861
First page :
Section Title :
Open access? :
No
Section Order :
11177